Certolizumab
Certolizumab (ser-toe-LIZ-oo-mab) is a biologic medication used in the treatment of several autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and Crohn's disease.
Etymology
The name "Certolizumab" is derived from the Latin roots "certo", meaning "certain", and "lizumab", a common suffix for monoclonal antibodies. This reflects the drug's specific action as a monoclonal antibody that targets certain proteins in the body.
Pharmacology
Certolizumab works by blocking the action of tumor necrosis factor alpha (TNFα), a substance in the body that causes inflammation. By inhibiting TNFα, certolizumab can reduce inflammation and slow the progression of autoimmune diseases.
Usage
Certolizumab is typically administered via subcutaneous injection. The dosage and frequency of administration can vary depending on the specific disease being treated and the patient's response to therapy.
Side Effects
Common side effects of certolizumab can include nausea, headache, and skin rash. More serious side effects can include infections, allergic reactions, and in rare cases, a worsening of the underlying autoimmune disease.
Related Terms
External links
- Medical encyclopedia article on Certolizumab
- Wikipedia's article - Certolizumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski